Streetwise Reports
The Gold Report
The Energy Report
The Life Sciences Report
Research Reports
Streetwise Reports
The Gold Report
The Energy Report
The Life Sciences Report
Research Reports
The Life Sciences Report
Articles
Biotechnology / Pharmaceuticals
Cannabis
Healthcare Services
Life Sciences Tools & Diagnostics
Medical Devices
Nutraceuticals
Disclosures
Featured news in
The Life Sciences Report
Mesoblast Ltd.
(MESO:NASDAQ; MSB:ASX)
Mesoblast Receives IND Clearance from FDA to Directly Proceed to Registrational Trial for Approval of Ryoncil® in Duchenne Muscular Dystrophy (4/7/2026)
view
Mesoblast Ltd.
(MESO:NASDAQ; MSB:ASX)
Ryoncil® Continues Successful First Year Launch with Net Sales of US$30.3M in March Quarter (4/6/2026)
view